Celcuity Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Research and development | $145.0M | $104.2M | $60.6M | $35.3M | $25.8M |
| Operating expenses | $172.2M | $113.3M | $66.2M | $39.4M | $28.4M |
| Operating income | -$172.2M | -$113.3M | -$66.2M | -$39.4M | -$28.4M |
| Interest expense | $17.1M | $10.3M | $5.3M | $2.1M | $1.3M |
| Pretax income | -$177.0M | -$111.8M | -$63.8M | -$40.4M | -$29.6M |
| Net income | -$177.0M | -$111.8M | -$63.8M | -$40.4M | -$29.6M |
| Balance Sheet | |||||
| Cash and equivalents | $165.7M | $22.5M | $30.7M | $24.6M | $84.3M |
| Current assets | $465.7M | $244.6M | $190.6M | $175.2M | $85.4M |
| Total assets | $466.6M | $245.1M | $191.2M | $175.7M | $85.9M |
| Current liabilities | $44.2M | $31.7M | $14.2M | $6.9M | $2.5M |
| Total liabilities | $366.0M | $129.5M | $51.5M | $41.9M | $17.2M |
| Stockholders' equity | $100.6M | $115.6M | $139.8M | $133.8M | $68.7M |
| Cash Flow Statement | |||||
| Cash from operations | -$153.3M | -$83.5M | -$53.8M | -$36.0M | -$20.3M |
| Depreciation and amortization | $167,000 | $130,000 | $142,772 | $210,918 | $303,235 |
| Stock-based compensation | $21.4M | $7.0M | $4.9M | $4.6M | $2.6M |
| Capital expenditure | $249,000 | $250,000 | $97,644 | $158,768 | $81,898 |
| Free cash flow | -$153.5M | -$83.7M | -$53.9M | -$36.2M | -$20.4M |
Shares outstanding 48.8M · Free float 47.1%
Annual filing data through FY ended December 31, 2025; float as of July 14, 2026.